No JH, Kim K, Park KH, Kim YB. Cell-free DNA Level as a Prognostic Biomarker for Epithelial Ovarian Cancer. Anticancer Res. 2012 Aug;32(8):3467-71.

No JH, Jeon YT, Park IA, Kim YB, Kim JW, Park NH, Kang SB, Han JY, Lim JM, Song YS. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. Gynecol Oncol. 2011 Apr;121(1):8-12

No JH, Kim MK, Jeon YT, Kim YB, Song YS. Human papillomavirus vaccine: Widening the scope for cancer prevention. Mol Carcinog.2011Apr;50(4):244-5

No JH, Jeon YT, Kim YB, Song YS. Quantitative detection of serum survivin and its relationship with prognostic factors in ovarian cancer. Gynecol Obstet Invest 2010. In press.

No JH, Jo H, Kim SH, Park IA, Kang D, Han SS, Kim JW, Park NH, Kang SB, Song YS. Expression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in cervical neoplasia. Ann N Y Acad Sci. 2009;1171:105-10.

No JH, Jeon YT, Park IA, Kang D, Kim JW, Park NH, Kang SB, Song YS. Expression of mTOR protein and its clinical significance in endometrial cancer. Med Sci Monit. 2009;15(10):BR301-305

No JH, Jo H, Kim SH, Park IA, Kang D, Lee CH, Han SS, Kim JW, Park NH, Kang SB, Song YS. Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia. Ann N Y Acad Sci. 2009;1171:100-4